Company intelligence / Profile preview

Office of Science and Innovation

Oxford, Oxfordshire, United Kingdom
Ownership
Private
Employees
~50
Development stage
Other
01

Overview

Oxford Science Enterprises (OSE), formerly known as Oxford Science Innovation (OSI), is a major independent investment company that builds and funds world-leading businesses based on scientific breakthroughs from the University of Oxford. Founded in 2015, the company focuses on three primary sectors: Life Sciences, Health Tech, and Deep Tech. OSE acts as a founding partner, providing capital, strategic guidance, and operational support to transform academic research into commercial enterprises. Its extensive portfolio includes over 100 companies, many of which are developing novel therapeutic modalities and diagnostic tools to address significant unmet medical needs. The firm plays a central role in the Oxford ecosystem, leveraging its unique partnership with the university to drive innovation in global healthcare.

Therapeutic areas
ImmunologyCardiovascularNeurologyInfectious DiseasesRare DiseasesOncology
Modalities
Small moleculeMonoclonal antibodyCell therapyGene therapymRNA-based drugsAntibody-drug conjugatePeptides
Industry
Investors
02

Partnerships

University of OxfordAstraZenecaBayerGoogle VenturesSequoia Capital

Beyond the preview

Go deeper on Office of Science and Innovation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Office of Science and Innovation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call